Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Pfizer Inc. : Pfizer Will Remove Claims on Breast and Colon Health From Centrum Label -Reuters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/05/2012 | 11:26pm CET

Pfizer Inc. (>> Pfizer Inc.) said it will remove claims that its Centrum multivitamin supplements promote breast and colon health from labels over the next six months, following a complaint by a watchdog group, Reuters reported Thursday.

The company will also revise websites and advertising for Centrum, the report said.

The report said the Center for Science in the Public Interest sent a letter to Pfizer Chief Executive Ian Read in April outlining its complaints and threatening a lawsuit if the claims weren't removed.

In a statement, Pfizer said it "disagrees with CSPI's concerns, but has agreed to make these changes in order to fully resolve the issues raised by the organization," Reuters reported.

Full story at http://www.reuters.com/article/2012/07/05/pfizer-centrum-idUSL2E8I5BR820120705

Write to nymonitoring@dowjones.com

Stocks mentioned in the article : Pfizer Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PFIZER INC
03/24 GLOBAL GLAUCOMA THERAPEUTICS MARKET : Allergan, Merck, Novartis, Pfizer, Santen..
03/24 PFIZER : Receives Positive CHMP Opinion for TRUMENBA® for Prevention of Meningoc..
03/24 PFIZER : FDA Grants Approval for BAVENCIO® (avelumab)
03/23DJPRESS RELEASE : FDA Grants Approval for -3-
03/23DJPRESS RELEASE : FDA Grants Approval for -2-
03/23DJPRESS RELEASE : FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immuno..
03/23 MERCK : FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Ap..
03/23 PFIZER : Launches Zavicefta™ ceftazidime-avibactam in the U.K. and Germany..
03/23 PFIZER : Girl in Facebook Live hanging was prescribed drug with suicide warning
03/23 INVESTORS : Stock Option Reports for Covered Call reports for Facebook, General ..
More news
Sector news : Pharmaceuticals - NEC
03/24 NOVO NORDISK A/S : EMA panel backs Novo Nordisk's haemophilia B drug
03/24 YouTube's bid to grab TV dollars imperiled by advertiser revolt
03/23 TEVA PHARMACEUTICAL INDUSTRIES : Pharm says media reports of up to 6,000 layoffs..
03/22 MYLAN : recalls 81,000 EpiPens outside U.S. after reports of failure
03/21DJSANOFI'S PRESCRIPTION FOR GROWTH : Drug Sales in the Middle Kingdom
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q2 2015 Update
2015 Antibiotics Stocks To Benefit From 21st Century Cures Act
2015 ISIS PHARMA STOCK DROPS ON GOOD NEWS : Re-Evaluating The Bull Case
2015 DOW DOGS : 14.63% More Returns From 5 Lowest Priced As Of August 6 Per indexArb
2015 Pfizer's GL-2045 an Orphan Drug for CIDP
Advertisement
Financials ($)
Sales 2017 53 525 M
EBIT 2017 20 455 M
Net income 2017 13 219 M
Debt 2017 25 072 M
Yield 2017 3,73%
P/E ratio 2017 14,11
P/E ratio 2018 13,39
EV / Sales 2017 4,28x
EV / Sales 2018 4,01x
Capitalization 204 201 M
More Financials
Chart PFIZER INC
Duration : Period :
Pfizer Inc Technical Analysis Chart | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 38,1 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
Ole Isacson Chief Scientific Officer
W. Don Cornwell Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC13.96%204 201
JOHNSON & JOHNSON8.91%341 301
ROCHE HOLDING LTD.8.60%219 164
PFIZER INC.4.68%204 201
NOVARTIS AG-0.94%196 550
MERCK & CO., INC.7.32%173 740
More Results